TP53 and colorectal carcinoma: For context, we compared the AF of PTEN mutations estimated to have LoF versus WT characteristics in tumors bearing APC, KRAS, PIK3CA, or TP53 mutations (Fig. 4d) in the MT-L subset, comprising the bulk of CRC samples.